{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:38:32Z","timestamp":1790095112344,"version":"4.0.1"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T00:00:00Z","timestamp":1741910400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016302","name":"Coalition for Epidemic Preparedness Innovations","doi-asserted-by":"publisher","award":["A08154"],"award-info":[{"award-number":["A08154"]}],"id":[{"id":"10.13039\/100016302","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016302","name":"Coalition for Epidemic Preparedness Innovations","doi-asserted-by":"publisher","award":["PRJ-6111"],"award-info":[{"award-number":["PRJ-6111"]}],"id":[{"id":"10.13039\/100016302","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["PRJ-6111"],"award-info":[{"award-number":["PRJ-6111"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015691","name":"National Institute of Allergy and Infectious Diseases Division of Microbiology and Infectious Diseases","doi-asserted-by":"publisher","award":["UC7AI094660"],"award-info":[{"award-number":["UC7AI094660"]}],"id":[{"id":"10.13039\/100015691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015691","name":"National Institute of Allergy and Infectious Diseases Division of Microbiology and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 A1132244"],"award-info":[{"award-number":["R01 A1132244"]}],"id":[{"id":"10.13039\/100015691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015691","name":"National Institute of Allergy and Infectious Diseases Division of Microbiology and Infectious Diseases","doi-asserted-by":"publisher","award":["AI125179"],"award-info":[{"award-number":["AI125179"]}],"id":[{"id":"10.13039\/100015691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015595","name":"GHR Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000861","name":"Burroughs Wellcome Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000861","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000866","name":"International AIDS Vaccine Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000866","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.ebiom.2025.105673","type":"journal-article","created":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T13:33:23Z","timestamp":1743600803000},"page":"105673","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Mapping the antibody response to Lassa virus vaccination of non-human primates"],"prefix":"10.1016","volume":"114","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8225-6688","authenticated-orcid":false,"given":"Adrian S.","family":"Enriquez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben Diaz","family":"Avalos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diptiben","family":"Parekh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5211-6502","authenticated-orcid":false,"given":"Christopher L.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin","family":"Morrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas W.","family":"Geisbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher L.","family":"Parks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn M.","family":"Hastie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1206-7451","authenticated-orcid":false,"given":"Erica Ollmann","family":"Saphire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ebiom.2025.105673_bib1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41579-022-00789-8","article-title":"Lassa fever - the road ahead","volume":"21","author":"Garry","year":"2023","journal-title":"Nat Rev Microbiol"},{"issue":"15","key":"10.1016\/j.ebiom.2025.105673_bib2","doi-asserted-by":"crossref","first-page":"6992","DOI":"10.1128\/JVI.74.15.6992-7004.2000","article-title":"Genetic diversity among Lassa virus strains","volume":"74","author":"Bowen","year":"2000","journal-title":"J\u00a0Virol"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105673_bib3","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3201\/eid2104.141469","article-title":"Sequence variability and geographic distribution of Lassa virus, Sierra Leone","volume":"21","author":"Leski","year":"2015","journal-title":"Emerg Infect Dis"},{"issue":"12","key":"10.1016\/j.ebiom.2025.105673_bib4","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.3201\/eid1212.060812","article-title":"Mastomys natalensis and Lassa fever, West Africa","volume":"12","author":"Lecompte","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ebiom.2025.105673_bib5","first-page":"75","article-title":"Lassa fever","volume":"262","author":"McCormick","year":"2002","journal-title":"Curr Top Microbiol Immunol"},{"issue":"10","key":"10.1016\/j.ebiom.2025.105673_bib6","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.3201\/eid1010.IM1010","article-title":"On the front lines of Lassa fever","volume":"10","author":"Bausch","year":"2004","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105673_bib7","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/infdis\/155.3.437","article-title":"A\u00a0prospective study of the epidemiology and ecology of Lassa fever","volume":"155","author":"McCormick","year":"1987","journal-title":"J\u00a0Infect Dis"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105673_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1008811","article-title":"Bridging the gap: using reservoir ecology and human serosurveys to estimate Lassa virus spillover in West Africa","volume":"17","author":"Basinski","year":"2021","journal-title":"PLoS Comput Biol"},{"issue":"6648","key":"10.1016\/j.ebiom.2025.105673_bib9","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1136\/bmj.297.6648.584","article-title":"A\u00a0prospective study of maternal and fetal outcome in acute Lassa fever infection during pregnancy","volume":"297","author":"Price","year":"1988","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105673_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002748","article-title":"Lassa fever in post-conflict sierra leone","volume":"8","author":"Shaffer","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105673_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-33112-3","article-title":"Predicting the evolution of the Lassa virus endemic area and population at risk over the next decades","volume":"13","author":"Klitting","year":"2022","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.ebiom.2025.105673_bib12","doi-asserted-by":"crossref","first-page":"466","DOI":"10.3201\/eid0605.000504","article-title":"Imported lassa fever in Germany: molecular characterization of a new lassa virus strain","volume":"6","author":"G\u00fcnther","year":"2000","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"10.1016\/j.ebiom.2025.105673_bib13","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3201\/eid1205.050052","article-title":"Historical Lassa fever reports and 30-year clinical update","volume":"12","author":"Macher","year":"2006","journal-title":"Emerg Infect Dis"},{"issue":"15","key":"10.1016\/j.ebiom.2025.105673_bib14","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2020.25.15.2000265","article-title":"Public health response to two imported, epidemiologically related cases of Lassa fever in the Netherlands (ex Sierra Leone), November 2019","volume":"25","author":"Overbosch","year":"2020","journal-title":"Euro Surveill"},{"key":"10.1016\/j.ebiom.2025.105673_bib15","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.antiviral.2018.09.009","article-title":"The WHO R&D Blueprint: 2018 review of emerging infectious diseases requiring urgent research and development efforts","volume":"159","author":"Mehand","year":"2018","journal-title":"Antiviral Res"},{"issue":"26","key":"10.1016\/j.ebiom.2025.105673_bib16","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1016\/j.vaccine.2020.01.017","article-title":"Meeting report: WHO consultation on accelerating Lassa fever vaccine development in endemic countries, Dakar, 10-11 September 2019","volume":"38","author":"Salami","year":"2020","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105673_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111094","article-title":"A\u00a0recombinant VSV-vectored vaccine rapidly protects nonhuman primates against heterologous lethal Lassa fever","volume":"40","author":"Cross","year":"2022","journal-title":"Cell Rep"},{"issue":"12","key":"10.1016\/j.ebiom.2025.105673_bib18","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/j.chom.2022.11.009","article-title":"Holding it together: nanoparticle stabilization of LASV trimer","volume":"30","author":"Gunn","year":"2022","journal-title":"Cell Host Microbe"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105673_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-37050-6","article-title":"Rapid protection induced by a single-shot Lassa vaccine in male cynomolgus monkeys","volume":"14","author":"Mateo","year":"2023","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105673_bib20","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00039-20","article-title":"A\u00a0Lassa fever live-attenuated vaccine based on codon deoptimization of the viral glycoprotein gene","volume":"11","author":"Cai","year":"2020","journal-title":"mBio"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105673_bib21","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1073\/pnas.86.1.317","article-title":"Protection of rhesus monkeys from fatal Lassa fever by vaccination with a recombinant vaccinia virus containing the Lassa virus glycoprotein gene","volume":"86","author":"Fisher-Hoch","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"10.1016\/j.ebiom.2025.105673_bib22","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/sj.embor.7400002","article-title":"Identification of Lassa virus glycoprotein signal peptide as a trans -acting maturation factor","volume":"4","author":"Eichler","year":"2003","journal-title":"EMBO Rep"},{"issue":"1\u20133","key":"10.1016\/j.ebiom.2025.105673_bib23","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0014-5793(03)00160-1","article-title":"Signal peptide of Lassa virus glycoprotein GP-C exhibits an unusual length","volume":"538","author":"Eichler","year":"2003","journal-title":"FEBS Lett"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105673_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005418","article-title":"Acidic pH-induced conformations and LAMP1 binding of the lassa virus glycoprotein spike","volume":"12","author":"Li","year":"2016","journal-title":"PLoS Pathog"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105673_bib25","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/0035-9203(85)90388-8","article-title":"Endemic Lassa fever in Liberia. IV. Selection of optimally effective plasma for treatment by passive immunization","volume":"79","author":"Jahrling","year":"1985","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"11","key":"10.1016\/j.ebiom.2025.105673_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005276","article-title":"Arenavirus glycan shield promotes neutralizing antibody evasion and protracted infection","volume":"11","author":"Sommerstein","year":"2015","journal-title":"PLoS Pathog"},{"issue":"28","key":"10.1016\/j.ebiom.2025.105673_bib27","doi-asserted-by":"crossref","first-page":"7320","DOI":"10.1073\/pnas.1803990115","article-title":"Structure of the Lassa virus glycan shield provides a model for immunological resistance","volume":"115","author":"Watanabe","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6341","key":"10.1016\/j.ebiom.2025.105673_bib28","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1126\/science.aam7260","article-title":"Structural basis for antibody-mediated neutralization of Lassa virus","volume":"356","author":"Hastie","year":"2017","journal-title":"Science"},{"issue":"5396","key":"10.1016\/j.ebiom.2025.105673_bib29","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1126\/science.282.5396.2079","article-title":"Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus","volume":"282","author":"Cao","year":"1998","journal-title":"Science"},{"issue":"6191","key":"10.1016\/j.ebiom.2025.105673_bib30","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1126\/science.1252480","article-title":"Lassa virus entry requires a trigger-induced receptor switch","volume":"344","author":"Jae","year":"2014","journal-title":"Science"},{"issue":"6064","key":"10.1016\/j.ebiom.2025.105673_bib31","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1126\/science.1214115","article-title":"Dystroglycan function requires xylosyl- and glucuronyltransferase activities of LARGE","volume":"335","author":"Inamori","year":"2012","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.ebiom.2025.105673_bib32","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/glycob\/cwv021","article-title":"Matriglycan: a novel polysaccharide that links dystroglycan to the basement membrane","volume":"25","author":"Yoshida-Moriguchi","year":"2015","journal-title":"Glycobiology"},{"issue":"9","key":"10.1016\/j.ebiom.2025.105673_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/v13091679","article-title":"Lassa fever virus binds matriglycan-A polymer of alternating xylose and glucuronate-on \u03b1-dystroglycan","volume":"13","author":"Joseph","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.ebiom.2025.105673_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11544","article-title":"Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits","volume":"7","author":"Robinson","year":"2016","journal-title":"Nat Commun"},{"issue":"668","key":"10.1016\/j.ebiom.2025.105673_bib35","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abq0991","article-title":"A\u00a0cocktail of protective antibodies subverts the dense glycan shield of Lassa virus","volume":"14","author":"Li","year":"2022","journal-title":"Sci Transl Med"},{"issue":"8","key":"10.1016\/j.ebiom.2025.105673_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110841","article-title":"Delineating the mechanism of anti-Lassa virus GPC-A neutralizing antibodies","volume":"39","author":"Enriquez","year":"2022","journal-title":"Cell Rep"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105673_bib37","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.01278-22","article-title":"Neutralizing antibodies against Lassa virus lineage I","volume":"13","author":"Buck","year":"2022","journal-title":"mBio"},{"key":"10.1016\/j.ebiom.2025.105673_bib38","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.cell.2019.07.020","article-title":"Convergent structures illuminate features for germline antibody binding and pan-lassa virus neutralization [Internet]","volume":"178","author":"Hastie","year":"2019","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105673_bib39","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/tmi.13876","article-title":"Lassa fever vaccine candidates: a scoping review of vaccine clinical trials","volume":"28","author":"Sulis","year":"2023","journal-title":"Trop Med Int Health"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105673_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003736","article-title":"A\u00a0recombinant vesicular stomatitis virus-based Lassa fever vaccine protects guinea pigs and macaques against challenge with geographically and genetically distinct Lassa viruses","volume":"9","author":"Safronetz","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105673_bib41","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1172\/JCI131958","article-title":"Quadrivalent VesiculoVax vaccine protects nonhuman primates from viral-induced hemorrhagic fever and death","volume":"130","author":"Cross","year":"2020","journal-title":"J\u00a0Clin Invest"},{"issue":"597","key":"10.1016\/j.ebiom.2025.105673_bib42","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abf6348","article-title":"A\u00a0single-shot Lassa vaccine induces long-term immunity and protects cynomolgus monkeys against heterologous strains","volume":"13","author":"Mateo","year":"2021","journal-title":"Sci Transl Med"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105673_bib43","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nmeth.4169","article-title":"cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination","volume":"14","author":"Punjani","year":"2017","journal-title":"Nat Methods"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105673_bib44","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/pro.3235","article-title":"UCSF ChimeraX: meeting modern challenges in visualization and analysis","volume":"27","author":"Goddard","year":"2018","journal-title":"Protein Sci"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105673_bib45","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1371\/journal.pmed.0020183","article-title":"Development of a new vaccine for the prevention of Lassa fever","volume":"2","author":"Geisbert","year":"2005","journal-title":"PLoS Med"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105673_bib46","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.immuni.2018.07.009","article-title":"Electron-microscopy-based epitope mapping defines specificities of polyclonal antibodies elicited during HIV-1 BG505 envelope trimer immunization","volume":"49","author":"Bianchi","year":"2018","journal-title":"Immunity"},{"issue":"11","key":"10.1016\/j.ebiom.2025.105673_bib47","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.1016\/j.celrep.2020.02.061","article-title":"Mapping polyclonal antibody responses in non-human primates vaccinated with HIV env trimer subunit vaccines","volume":"30","author":"Nogal","year":"2020","journal-title":"Cell Rep"},{"key":"10.1016\/j.ebiom.2025.105673_bib48","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.64281","article-title":"High-resolution mapping of the neutralizing and binding specificities of polyclonal sera post-HIV Env trimer vaccination","volume":"10","author":"Dingens","year":"2021","journal-title":"Elife"},{"issue":"31","key":"10.1016\/j.ebiom.2025.105673_bib49","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abh2791","article-title":"Disassembly of HIV envelope glycoprotein trimer immunogens is driven by antibodies elicited via immunization","volume":"7","author":"Turner","year":"2021","journal-title":"Sci Adv"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105673_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108682","article-title":"Polyclonal epitope mapping reveals temporal dynamics and diversity of human antibody responses to H5N1 vaccination","volume":"34","author":"Han","year":"2021","journal-title":"Cell Rep"},{"issue":"18","key":"10.1016\/j.ebiom.2025.105673_bib51","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abn2911","article-title":"Structural mapping of antibody landscapes to human betacoronavirus spike proteins","volume":"8","author":"Bangaru","year":"2022","journal-title":"Sci Adv"},{"issue":"5","key":"10.1016\/j.ebiom.2025.105673_bib52","doi-asserted-by":"crossref","DOI":"10.1093\/pnasnexus\/pgac253","article-title":"High-resolution structural analysis of enterovirus-reactive polyclonal antibodies in complex with whole virions","volume":"1","author":"Antanasijevic","year":"2022","journal-title":"PNAS Nexus"},{"issue":"16","key":"10.1016\/j.ebiom.2025.105673_bib53","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00480-22","article-title":"Structural study of SARS-CoV-2 antibodies identifies a broad-spectrum antibody that neutralizes the omicron variant by disassembling the spike trimer","volume":"96","author":"Zhan","year":"2022","journal-title":"J\u00a0Virol"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105673_bib54","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.cell.2020.06.025","article-title":"Structures of human antibodies bound to SARS-CoV-2 spike reveal common epitopes and recurrent features of antibodies","volume":"182","author":"Barnes","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ebiom.2025.105673_bib55","first-page":"1","article-title":"Successful vaccines","volume":"428","author":"Amanna","year":"2020","journal-title":"Curr Top Microbiol Immunol"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105673_bib56","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3201\/eid2102.141649","article-title":"Vesicular stomatitis virus-based vaccines against Lassa and Ebola viruses","volume":"21","author":"Marzi","year":"2015","journal-title":"Emerg Infect Dis"},{"issue":"8","key":"10.1016\/j.ebiom.2025.105673_bib57","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1128\/JVI.05991-11","article-title":"The immune response to a vesicular stomatitis virus vaccine vector is independent of particulate antigen secretion and protein turnover rate","volume":"86","author":"Cobleigh","year":"2012","journal-title":"J\u00a0Virol"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105673_bib58","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41594-022-00735-5","article-title":"The SARS-CoV-2 spike reversibly samples an open-trimer conformation exposing novel epitopes","volume":"29","author":"Costello","year":"2022","journal-title":"Nat Struct Mol Biol"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105673_bib59","doi-asserted-by":"crossref","first-page":"4676","DOI":"10.1038\/s41467-023-40321-x","article-title":"Structures and immune recognition of Env trimers from two Asia prevalent HIV-1 CRFs","volume":"14","author":"Niu","year":"2023","journal-title":"Nat Commun"},{"issue":"6630","key":"10.1016\/j.ebiom.2025.105673_bib60","doi-asserted-by":"crossref","DOI":"10.1126\/science.abn8934","article-title":"Low protease activity in B cell follicles promotes retention of intact antigens after immunization","volume":"379","author":"Aung","year":"2023","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105673_bib61","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.cell.2019.12.027","article-title":"Slow delivery immunization enhances HIV neutralizing antibody and germinal center responses via modulation of immunodominance","volume":"180","author":"Cirelli","year":"2020","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.ebiom.2025.105673_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112524","article-title":"Structural conservation of Lassa virus glycoproteins and recognition by neutralizing antibodies","volume":"42","author":"Perrett","year":"2023","journal-title":"Cell Rep"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105673_bib63","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41467-023-44534-y","article-title":"Cleavage-intermediate Lassa virus trimer elicits neutralizing responses, identifies neutralizing nanobodies, and reveals an apex-situated site-of-vulnerability","volume":"15","author":"Gorman","year":"2024","journal-title":"Nat Commun"},{"issue":"12","key":"10.1016\/j.ebiom.2025.105673_bib64","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/j.chom.2022.10.018","article-title":"Lassa virus glycoprotein nanoparticles elicit neutralizing antibody responses and protection","volume":"30","author":"Brouwer","year":"2022","journal-title":"Cell Host Microbe"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396425001173?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396425001173?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T16:18:16Z","timestamp":1762618696000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396425001173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":64,"alternative-id":["S2352396425001173"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.105673","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mapping the antibody response to Lassa virus vaccination of non-human primates","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.105673","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.105647","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105673"}}